Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__87_B7,13 | Lung | Primary cancer | 258 | Tumor/Malignant | 72.5% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__87_B7,14 | Lung | Primary cancer | 3,100 | Tumor/Malignant | 36.2% | 0.91 | 0.25 |
| NSCLC_38242124__IMC__87_B7,15 | Lung | Primary cancer | 3,931 | Tumor/Malignant | 40.4% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__87_B7,2 | Lung | Primary cancer | 3,415 | Tumor/Malignant | 62.1% | 0.96 | 0.16 |
| NSCLC_38242124__IMC__87_B7,3 | Lung | Primary cancer | 3,574 | Tumor/Malignant | 82.6% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__87_B7,4 | Lung | Primary cancer | 3,143 | Tumor/Malignant | 62.0% | 1.00 | 0.03 |
| NSCLC_38242124__IMC__87_B7,5 | Lung | Primary cancer | 3,066 | Tumor/Malignant | 47.1% | 0.88 | 0.31 |
| NSCLC_38242124__IMC__87_B7,6 | Lung | Primary cancer | 2,135 | Tumor/Malignant | 73.3% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__87_B7,7 | Lung | Primary cancer | 3,468 | Tumor/Malignant | 66.7% | 1.00 | 0.01 |
| NSCLC_38242124__IMC__87_B7,8 | Lung | Primary cancer | 2,078 | Tumor/Malignant | 59.4% | 0.97 | 0.15 |
| NSCLC_38242124__IMC__87_B7,9 | Lung | Primary cancer | 2,847 | Tumor/Malignant | 70.1% | 0.97 | 0.14 |
| NSCLC_38242124__IMC__87_B8,1 | Lung | Primary cancer | 3,125 | Tumor/Malignant | 55.5% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__87_B8,10 | Lung | Primary cancer | 4,837 | Tumor/Malignant | 64.3% | 0.93 | 0.19 |
| NSCLC_38242124__IMC__87_B8,11 | Lung | Primary cancer | 3,758 | Tumor/Malignant | 90.8% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__87_B8,12 | Lung | Primary cancer | 4,425 | Tumor/Malignant | 84.2% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__87_B8,13 | Lung | Primary cancer | 2,232 | Tumor/Malignant | 73.9% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__87_B8,14 | Lung | Primary cancer | 3,660 | Tumor/Malignant | 40.9% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__87_B8,15 | Lung | Primary cancer | 3,908 | Tumor/Malignant | 75.2% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__87_B8,16 | Lung | Primary cancer | 3,067 | Tumor/Malignant | 31.8% | 0.82 | 0.49 |
| NSCLC_38242124__IMC__87_B8,17 | Lung | Primary cancer | 2,724 | Tumor/Malignant | 35.2% | 0.96 | 0.15 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__87_B7,13 | Lung | Primary cancer | 258 | Tumor/Malignant | 72.5% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__87_B7,14 | Lung | Primary cancer | 3,100 | Tumor/Malignant | 35.6% | 0.91 | 0.24 |
| NSCLC_38242124__IMC__87_B7,15 | Lung | Primary cancer | 3,931 | Tumor/Malignant | 41.3% | 0.97 | 0.13 |
| NSCLC_38242124__IMC__87_B7,2 | Lung | Primary cancer | 3,415 | Tumor/Malignant | 53.9% | 0.98 | 0.11 |
| NSCLC_38242124__IMC__87_B7,3 | Lung | Primary cancer | 3,574 | Tumor/Malignant | 81.2% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__87_B7,4 | Lung | Primary cancer | 3,143 | Tumor/Malignant | 62.5% | 1.00 | 0.04 |
| NSCLC_38242124__IMC__87_B7,5 | Lung | Primary cancer | 3,066 | Tumor/Malignant | 29.5% | 0.96 | 0.14 |
| NSCLC_38242124__IMC__87_B7,6 | Lung | Primary cancer | 2,135 | Tumor/Malignant | 73.4% | 0.96 | 0.12 |
| NSCLC_38242124__IMC__87_B7,7 | Lung | Primary cancer | 3,468 | Tumor/Malignant | 67.0% | 1.00 | 0.01 |
| NSCLC_38242124__IMC__87_B7,8 | Lung | Primary cancer | 2,078 | Tumor/Malignant | 44.8% | 0.88 | 0.32 |
| NSCLC_38242124__IMC__87_B7,9 | Lung | Primary cancer | 2,847 | Tumor/Malignant | 69.7% | 0.97 | 0.14 |
| NSCLC_38242124__IMC__87_B8,1 | Lung | Primary cancer | 3,125 | Tumor/Malignant | 55.6% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__87_B8,10 | Lung | Primary cancer | 4,837 | Tumor/Malignant | 42.8% | 1.00 | 0.03 |
| NSCLC_38242124__IMC__87_B8,11 | Lung | Primary cancer | 3,758 | Tumor/Malignant | 89.3% | 1.00 | 0.03 |
| NSCLC_38242124__IMC__87_B8,12 | Lung | Primary cancer | 4,425 | Tumor/Malignant | 72.0% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__87_B8,13 | Lung | Primary cancer | 2,232 | Tumor/Malignant | 75.2% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__87_B8,14 | Lung | Primary cancer | 3,660 | Tumor/Malignant | 50.1% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__87_B8,15 | Lung | Primary cancer | 3,908 | Tumor/Malignant | 73.0% | 1.00 | 0.03 |
| NSCLC_38242124__IMC__87_B8,16 | Lung | Primary cancer | 3,067 | Lymphoid | 24.5% | 0.95 | 0.15 |
| NSCLC_38242124__IMC__87_B8,17 | Lung | Primary cancer | 2,724 | Tumor/Malignant | 35.3% | 0.96 | 0.16 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__87_B7,13 | Lung | Primary cancer | 258 | Tumor/Malignant cell | 77.5% | 0.95 | 0.15 |
| NSCLC_38242124__IMC__87_B7,14 | Lung | Primary cancer | 3,100 | Tumor/Malignant cell | 35.7% | 0.92 | 0.24 |
| NSCLC_38242124__IMC__87_B7,15 | Lung | Primary cancer | 3,931 | Tumor/Malignant cell | 42.1% | 0.96 | 0.15 |
| NSCLC_38242124__IMC__87_B7,2 | Lung | Primary cancer | 3,415 | Tumor/Malignant cell | 60.6% | 0.96 | 0.15 |
| NSCLC_38242124__IMC__87_B7,3 | Lung | Primary cancer | 3,574 | Tumor/Malignant cell | 81.8% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__87_B7,4 | Lung | Primary cancer | 3,143 | Tumor/Malignant cell | 74.0% | 0.97 | 0.11 |
| NSCLC_38242124__IMC__87_B7,5 | Lung | Primary cancer | 3,066 | Tumor/Malignant cell | 47.5% | 0.87 | 0.32 |
| NSCLC_38242124__IMC__87_B7,6 | Lung | Primary cancer | 2,135 | Tumor/Malignant cell | 73.5% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__87_B7,7 | Lung | Primary cancer | 3,468 | Tumor/Malignant cell | 82.8% | 0.99 | 0.02 |
| NSCLC_38242124__IMC__87_B7,8 | Lung | Primary cancer | 2,078 | Tumor/Malignant cell | 58.3% | 0.97 | 0.15 |
| NSCLC_38242124__IMC__87_B7,9 | Lung | Primary cancer | 2,847 | Tumor/Malignant cell | 66.9% | 0.98 | 0.13 |
| NSCLC_38242124__IMC__87_B8,1 | Lung | Primary cancer | 3,125 | Tumor/Malignant cell | 57.5% | 0.96 | 0.10 |
| NSCLC_38242124__IMC__87_B8,10 | Lung | Primary cancer | 4,837 | Tumor/Malignant cell | 63.2% | 0.93 | 0.19 |
| NSCLC_38242124__IMC__87_B8,11 | Lung | Primary cancer | 3,758 | Tumor/Malignant cell | 90.9% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__87_B8,12 | Lung | Primary cancer | 4,425 | Tumor/Malignant cell | 84.5% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__87_B8,13 | Lung | Primary cancer | 2,232 | Tumor/Malignant cell | 75.9% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__87_B8,14 | Lung | Primary cancer | 3,660 | Tumor/Malignant cell | 64.6% | 0.92 | 0.23 |
| NSCLC_38242124__IMC__87_B8,15 | Lung | Primary cancer | 3,908 | Tumor/Malignant cell | 74.8% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__87_B8,16 | Lung | Primary cancer | 3,067 | Tumor/Malignant cell | 31.8% | 0.82 | 0.50 |
| NSCLC_38242124__IMC__87_B8,17 | Lung | Primary cancer | 2,724 | Tumor/Malignant cell | 35.3% | 0.95 | 0.16 |